Associate Professor Jonathan Morris obtained his B.Sc. (Hons) from the University of Western Australia and his Ph.D. degree with Professor Lew Mander in 1994 from The Australian National University in Canberra, Australia. After a postdoctoral appointment with Professor Phil Magnus at the University of Texas at Austin, he took up his first academic position at the University of Canterbury, New Zealand in 1997. In 2004, he moved to the University of Adelaide. In late 2009, he moved to the School of Chemistry at the University of New South Wales.
His research interests span from medicinal chemistry to chemical biology, with a particular expertise being in the synthesis of new molecules with biological activity. His research group has a strong reputation in the field of the synthesis of biologically active natural products and in particular, natural products that are kinase inhibitors. He has been involved in a number of translational drug discovery programs. He designed and developed the SPHINX molecules that are potent inhibitors of the RNA splicing kinase SRPK1.
Associate Professor Morris was awarded the Vice-Chancellors Award for Teaching Excellence in Postgraduate Supervision in 2014.